The company will apply its machine learning technology to improve the production of oligonucleotide therapeutics in partnership with CPI.
I
Intellegens
Intellegens builds machine learning software to accelerate research and development processes.
Cambridge, UK—Founded 2017
£1.6MTotal raised
Cambridge-based Intellegens provides machine learning software designed to help industrial research and development teams make sense of sparse data.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Cash, assets and headcount from Intellegens's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Founders

Ben Pellegrini
CEO
Ben is the chief executive officer and co-founder of Intellegens. His background includes roles as chief technology officer at CambridgeIP and senior software engineer at the Eastern Cancer Registry and Information Centre.
LinkedInInvestors

Funding history
£1.6M